| - GRCh37:
- Chr11:111779654
- GRCh38:
- Chr11:111908930
| CRYAB | K54R, K121R | Dilated cardiomyopathy 1II, Myofibrillar myopathy 2, Cataract 16 multiple types, Fatal infantile hypertonic myofibrillar myopathy, Dilated cardiomyopathy 1II | Uncertain significance (Dec 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111779513
- GRCh38:
- Chr11:111908789
| CRYAB | A101G, A168G | Myofibrillar myopathy 2, Dilated cardiomyopathy 1II | Uncertain significance (Oct 25, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111781056
- GRCh38:
- Chr11:111910332
| CRYAB | R107C, R40C | Dilated cardiomyopathy 1II, not provided, Dilated cardiomyopathy 1II, Cataract 16 multiple types, Myofibrillar myopathy 2, Fatal infantile hypertonic myofibrillar myopathy
| Uncertain significance (Feb 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111782408
- GRCh38:
- Chr11:111911684
| CRYAB | F14S | Dilated cardiomyopathy 1II, Myofibrillar myopathy 2 | Uncertain significance (May 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111782415
- GRCh38:
- Chr11:111911691
| CRYAB | R12C | not provided, Dilated cardiomyopathy 1II, Myofibrillar myopathy 2
| Conflicting interpretations of pathogenicity (Mar 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:111782412
- GRCh38:
- Chr11:111911688
| CRYAB | P13T | Cardiovascular phenotype, Dilated cardiomyopathy 1II, not provided, Cataract 16 multiple types, Dilated cardiomyopathy 1II, Fatal infantile hypertonic myofibrillar myopathy, Myofibrillar myopathy 2 | Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111779497
- GRCh38:
- Chr11:111908773
| CRYAB | K107fs, K174fs | Myofibrillar myopathy 2 | Uncertain significance (Mar 19, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:111782418
- GRCh38:
- Chr11:111911694
| CRYAB | R11G | Cataract 16 multiple types, Fatal infantile hypertonic myofibrillar myopathy, Dilated cardiomyopathy 1II, Myofibrillar myopathy 2, not provided, Dilated cardiomyopathy 1II
| Uncertain significance (Aug 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111782273
- GRCh38:
- Chr11:111911549
| CRYAB | S59N | Cataract 16 multiple types, Myofibrillar myopathy 2, Fatal infantile hypertonic myofibrillar myopathy
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:111779428
- GRCh38:
- Chr11:111908704
| CRYAB | | Fatal infantile hypertonic myofibrillar myopathy, Cataract 16 multiple types, Myofibrillar myopathy 2
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:111779534
- GRCh38:
- Chr11:111908810
| CRYAB | I161T, I94T | Fatal infantile hypertonic myofibrillar myopathy, Cataract 16 multiple types, Myofibrillar myopathy 2, not provided, Hypertrophic cardiomyopathy | Uncertain significance (Mar 1, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111779502
- GRCh38:
- Chr11:111908778
| CRYAB | A105fs, A172fs | Myofibrillar myopathy 2 | Pathogenic (Dec 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:111782330
- GRCh38:
- Chr11:111911606
| CRYAB | T40M | Dilated cardiomyopathy 1II, Myofibrillar myopathy 2, Fatal infantile hypertonic myofibrillar myopathy, Dilated cardiomyopathy 1II, Cataract 16 multiple types | Uncertain significance (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111782334
- GRCh38:
- Chr11:111911610
| CRYAB | P39S | Cardiovascular phenotype, Dilated cardiomyopathy 1II, Myofibrillar myopathy 2, Fatal infantile hypertonic myofibrillar myopathy, Dilated cardiomyopathy 1II, Cataract 16 multiple types
| Uncertain significance (Jun 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111781100
- GRCh38:
- Chr11:111910376
| CRYAB | K25R, K92R | Cataract 16 multiple types, Myofibrillar myopathy 2, Dilated cardiomyopathy 1II, Fatal infantile hypertonic myofibrillar myopathy, Dilated cardiomyopathy 1II, not provided
| Uncertain significance (Mar 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111782334
- GRCh38:
- Chr11:111911610
| CRYAB | P39A | Cardiovascular phenotype, not provided, Myofibrillar myopathy 2, Fatal infantile hypertonic myofibrillar myopathy, Cataract 16 multiple types, Dilated cardiomyopathy 1II, Dilated cardiomyopathy 1II | Uncertain significance (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111782384
- GRCh38:
- Chr11:111911660
| CRYAB | R22H | Myofibrillar myopathy 2, Dilated cardiomyopathy 1II, Fatal infantile hypertonic myofibrillar myopathy, Cataract 16 multiple types, Dilated cardiomyopathy 1II, not provided
| Uncertain significance (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111781031-111781032
- GRCh38:
- Chr11:111910307-111910308
| CRYAB | | Myofibrillar myopathy 2, Dilated cardiomyopathy 1II, Cataract 16 multiple types, Fatal infantile hypertonic myofibrillar myopathy, not specified, Dilated cardiomyopathy 1II
| Benign/Likely benign (May 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111779649
- GRCh38:
- Chr11:111908925
| CRYAB | R123W, R56W | not provided, Myofibrillar myopathy 2, Cataract 16 multiple types, Dilated cardiomyopathy 1II, Fatal infantile hypertonic myofibrillar myopathy, Dilated cardiomyopathy 1II
| Uncertain significance (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111782347
- GRCh38:
- Chr11:111911623
| CRYAB | E34D | Myofibrillar Myopathy, Dominant, Myofibrillar myopathy 2, Dilated cardiomyopathy 1II, Cataract 16 multiple types, Fatal infantile hypertonic myofibrillar myopathy, Fatal infantile hypertonic myofibrillar myopathy, Cataract 16 multiple types | Uncertain significance (Jul 20, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111779450
- GRCh38:
- Chr11:111908726
| CRYAB | | Fatal infantile hypertonic myofibrillar myopathy, Myofibrillar myopathy 2, Cataract 16 multiple types
| Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:111779449
- GRCh38:
- Chr11:111908725
| CRYAB | | Posterior polar cataract, Myofibrillar Myopathy, Dominant, Myofibrillar myopathy 2
| Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:111782433
- GRCh38:
- Chr11:111911709
| CRYAB | H6Y | Myofibrillar myopathy 2, Fatal infantile hypertonic myofibrillar myopathy, Cataract 16 multiple types, Dilated cardiomyopathy 1II, not provided | Uncertain significance (Sep 3, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111782333
- GRCh38:
- Chr11:111911609
| CRYAB | P39L | Cardiovascular phenotype, not specified, not provided, Dilated cardiomyopathy 1II, Fatal infantile hypertonic myofibrillar myopathy, Cataract 16 multiple types, Myofibrillar myopathy 2 | Conflicting interpretations of pathogenicity (Mar 10, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:111782389
- GRCh38:
- Chr11:111911665
| CRYAB | | Cardiovascular phenotype, not specified, Dilated cardiomyopathy 1II, Cardiomyopathy, Fatal infantile hypertonic myofibrillar myopathy, Cataract 16 multiple types, Myofibrillar myopathy 2 | Benign (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111781047
- GRCh38:
- Chr11:111910323
| CRYAB | | Myofibrillar Myopathy, Dominant, Cardiovascular phenotype, not specified, Dilated cardiomyopathy 1II, Fatal infantile hypertonic myofibrillar myopathy, Myofibrillar myopathy 2, Cataract 16 multiple types | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111782297
- GRCh38:
- Chr11:111911573
| CRYAB | P51L | Cardiovascular phenotype, Dilated cardiomyopathy 1II, not specified, not provided, Cardiomyopathy, Fatal infantile hypertonic myofibrillar myopathy, Myofibrillar myopathy 2, Cataract 16 multiple types | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:111779691
- GRCh38:
- Chr11:111908967
| CRYAB | D109H, D42H | Myofibrillar myopathy 2 | Pathogenic (Jan 1, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr11:111779546
- GRCh38:
- Chr11:111908822
| CRYAB | R157H, R90H | Cardiovascular phenotype, Dilated cardiomyopathy 1II, Fatal infantile hypertonic myofibrillar myopathy, Cataract 16 multiple types, Myofibrillar myopathy 2, Dilated cardiomyopathy 1II
| Uncertain significance (Dec 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111779673
- GRCh38:
- Chr11:111908949
| CRYAB | S48fs, S115fs | Dilated cardiomyopathy 1II, Myofibrillar myopathy 2, Cataract 16 multiple types, Fatal infantile hypertonic myofibrillar myopathy, Dilated cardiomyopathy 1II, not provided
| Pathogenic/Likely pathogenic (Feb 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111782389
- GRCh38:
- Chr11:111911665
| CRYAB | S21fs | Myofibrillar myopathy 2 | Pathogenic (May 1, 2011) | no assertion criteria provided |
| - GRCh37:
- Chr11:111779565
- GRCh38:
- Chr11:111908841
| CRYAB | Q151*, Q84* | Myofibrillar myopathy 2 | Pathogenic (Dec 1, 2003) | no assertion criteria provided |
| - GRCh37:
- Chr11:111779551-111779552
- GRCh38:
- Chr11:111908827-111908828
| CRYAB | P88fs, P155fs | Myofibrillar myopathy 2 | Pathogenic (Dec 1, 2003) | no assertion criteria provided |
| - GRCh37:
- Chr11:111779658
- GRCh38:
- Chr11:111908934
| CRYAB | R120G, R53G | Myofibrillar myopathy 2 | Pathogenic (Apr 7, 2006) | no assertion criteria provided |